The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
Affiliations: Department of Clinical Oncology, Toho University Graduate School of Medicine, Tokyo 143-8541, Japan, Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo 143-8541, Japan, Stroke Center, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong 510630, P.R. China, Department of Anesthesiology, Stroke Center, The First Affiliated Hospital and Health Science Center, Jinan University, Guangzhou, Guangdong 510630, P.R. China, Port Square Kashiwado Clinic, Kashiwado Memorial Foundation, Chiba 260-0025, Japan, Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
- Published online on: January 31, 2023 https://doi.org/10.3892/mi.2023.71
- Article Number: 11
Copyright : © Ito et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].